The Ramsay Health Care (ASX:RHC) share price has tumbled 7% this month. Is it a buy?

Is now the time to buy Ramsay shares?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price has been underperforming in 2021.

Since the start of the year, the private hospital operator's shares have risen just 5.5%. This follows a 7% decline so far in November.

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused.

Image source: Getty Images

Is the Ramsay share price good value now?

The subdued performance of the Ramsay share price this year has been driven by concerns over the difficult trading conditions the company is facing in Australia from lockdowns.

The good news, though, is that the team at Goldman Sachs believe this underperformance is a buying opportunity for investors.

According to a recent note, the broker has reiterated its buy rating and $74.00 price target on its shares.

Based on the current Ramsay share price of $66.20, this implies potential upside of approximately 12% for investors over the next 12 months.

Goldman is also forecasting a dividend yield of approximately 2% in FY 2022, bringing the total return on offer to ~14%.

Why does Goldman like Ramsay?

Goldman continues to highlight Ramsay as one of the more attractive recovery trades across its coverage.

It commented: "RHC's operating performance in 1Q22 was heavily impacted by various restrictions, lockdowns and other challenges associated with the pandemic. However: 1) these dynamics were widely understood (and experienced by most) prior to today; and 2) positive revenue growth (+1.3%) was ahead of our expectations given the severity of disruption during the period (widespread elective surgery bans/restrictions, isolation orders/lockdowns and infection-driven staffing shortages/procedure cancellations)."

"Despite these challenges, growth was positive in each of UK (+21%), Europe (+5%) and Asia (+15%), as the extent of volume recovery more than offset the impact of Covid-driven disruption and, whilst operating performance remains some way below pre-Covid levels, an improving trajectory is clear, and we believe the set-up for 2022 looks favourable," the broker added.

All in all, Goldman Sachs appears to believe it could be worth sticking with the Ramsay share price and sees strong returns on the horizon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Woman and man calculating a dividend yield.
Broker Notes

Buy, hold, sell: REA, Northern Star Resources, Suncorp shares

Two experts share their views on three ASX 200 shares.

Read more »

Two female executives looking at a clipboard together.
Broker Notes

Buy, hold, sell: Centuria Industrial REIT, Endeavour, Wildcat Resources shares

Experts share their views on the lithium miner, hotels operator, and industrial ASX REIT.

Read more »

A group of five engineers wearing hard hats and some in high visibility vests raise their arms in happy celebration atop a building site with construction and equipment in the background.
Broker Notes

Why this $1.4 billion ASX All Ords mining stock is tipped to jump 30%

A top wealth manager forecasts more than 30% returns from this ASX mining stock.

Read more »

A man in a business suit sits at his desk with a laptop and smiles broadly in an office setting, giving an air of optimism and confidence.
Broker Notes

Buy, hold, sell: Bank of Queensland, Xero, PLS Group shares

Let's check out some new ratings on ASX 200 shares today.

Read more »

Piles of increasing coins on Australian $100 notes.
Broker Notes

3 reasons to buy this rebounding ASX 200 dividend stock today

A leading analyst expects the rebound in this ASX 200 dividend stock has legs.

Read more »

Excited couple celebrating success while looking at smartphone.
Broker Notes

Where to invest $5,000 in Australian shares now

Brokers rate these shares as buys. Here's why they could be top picks.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Experts name 3 ASX shares to buy this week

These shares have been given the thumbs up by experts this week. Let's find out why.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: Endeavour, JB Hi-Fi, and New Hope shares 

Bell Potter has given its verdict on these shares following their results.

Read more »